22.418 articles found

Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene.

Zhuo M, Xu DH, Cao L, Xu LF, Yu FR, Zheng ZC, Liu XY.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) · 2003-12-01

PMID: 14673496

Treatments of Parkinson disease: circa 2003.

Shults CW.

Arch Neurol · 2003-12-01

DOI: 10.1001/archneur.60.12.1680PMID: 14676041

A controlled trial of rotigotine monotherapy in early Parkinson's disease.

Parkinson Study Group.

Arch Neurol · 2003-12-01

DOI: 10.1001/archneur.60.12.1721PMID: 14676046

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.

Calon F, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T.

Neurobiol Dis · 2003-12-01

DOI: 10.1016/j.nbd.2003.07.003PMID: 14678757

Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases.

Pong K, Zaleska MM.

Curr Drug Targets CNS Neurol Disord · 2003-12-01

DOI: 10.2174/1568007033482652PMID: 14683462

Therapeutic approaches to protein-misfolding diseases.

Cohen FE, Kelly JW.

Nature · 2003-12-01

DOI: 10.1038/nature02265PMID: 14685252

Involuntary expiratory phonation as a dose-related consequence of L-dopa therapy in a patient with Parkinson's disease.

Ishii K, Kumada M, Ueki A, Yamamoto M, Hirose H.

Ann Otol Rhinol Laryngol · 2003-12-01

DOI: 10.1177/000348940311201208PMID: 14703107

[A case of ovarian cancer with Parkinson's disease treated by combined chemotherapy with paclitaxel and carboplatin followed by surgery].

Furukawa M, Fujiwara H, Urabe S, Egawa M, Fujitoh N, Sakashita T, Date K, Mizunoe T, Ueda K, Urabe T.

Gan To Kagaku Ryoho · 2003-12-01

PMID: 14712777

[Parkinson disease therapy: how great is the progress? Possibilities, limitations and future prospects?].

Schulz-Hanke I.

Dtsch Med Wochenschr · 2003-12-01

PMID: 14725284

Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.

Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A.

Can J Psychiatry · 2003-12-01

DOI: 10.1177/070674370304801102PMID: 14733451

TREATMENT OF NEURODEGENERATIVE DISEASE THROUGH INTRACRANIAL DELIVERY OF SHORT INTERFERING RNA (SIRNA)

KAEMMERER William F..

· 2003-11-26

Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA)

KAEMMERER WILLIAM F.

· 2003-11-26